Aberrant expression of NK cell receptors in Epstein-Barr virus-positive γδ T-cell lymphoproliferative disorders

Hematology

Volumn 15, Issue 1, 2010, Pages 43-47

  Zhang, Yu ^a   Ohyashiki, Junko H ^a   Shimizu, Norio ^b   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Gamma delta t cell; Lymphoproliferative disorder; Nature killer cell associated receptor

Indexed keywords

CD161 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; NATURAL KILLER CELL RECEPTOR;

ARTICLE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UNINDEXED SEQUENCE; VIRUS INFECTION;

ANTIGENS, CD; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; INTEGRIN BETA3; LECTINS, C-TYPE; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, NATURAL KILLER CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS;

EID: 76749131116     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453310X12583347009450     Document Type: Article

References (20)

1. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336-1245
2. Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 2007; 127: 869-880.
3. Arnulf B, Copie-Bergman C, Delfau-Larue MH et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723-1731.
4. Zhang Y, Ohyashiki JH, Takaku T, Shimizu N, Ohyashiki K. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 2006; 94: 599-608.
5. Ohshima K, Kimura H, Yoshino T et al. CAEBV Study Group: proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Inter 2008; 58: 209-217.
6. Miyazaki K, Yamaguchi M, Imai H et al. Gene expression profiling of peripheral T-cell lymphoma including {gamma}{delta} T-cell lymphoma. Blood 2008; 113: 1071-1074.
7. Zhang Y, Nagata H, Ikeuchi T et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/ NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003; 121: 805-814.
8. Oyoshi MK, Nagata H, Kimura N et al. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol 2003 162: 1629-1638.
9. Sato K, Kimura S, Segawa H et al. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Int J Cancer 2005; 116: 94-99.
10. Ohyashiki JH, Hisatomi H, Nagao K et al. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells. Br J Cancer 2005; 92: 1942-1947.
11. Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 1993; 67: 2209-2220.
12. Sallusto F, Lanzavecchia A. Understanding dendritic cell and Tlymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000; 177: 134-140.
13. Nagato T, Kobayashi H, Kishibe K et al. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin Cancer Res 2005; 11: 8250-8257.
14. Jansen CA, Cruijsen CW, de Ruiter T et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007; 37: 914-924.
15. Tassi I, Klesney-Tait J, Colonna M. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse. Immunol Rev 2006; 214: 92-105.
16. Leung W, Iyengar R, Triplett B et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540-6545.
17. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004; 4: 190-198.
18. Halary F, Peyrat MA, Champagne E et al. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997; 27: 2812-2821
19. Voehringer D, Blaser C, Brawand P et al. Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol 2001; 167: 4838-4843.
20. Robbins SH, Nguyen KB, Takahashi N et al. Inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol 2002; 168: 2585-2589.